News | January 26, 2022
Astec LifeSciences Q3FY22 PAT at Rs 24.74 cr.
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
The current round is led by IIFL Asset Management (IIFL AMC) along with investment from existing investors InvestCorp and Bessemer Venture Partners (BVP)
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Board declares interim dividend of Rs 2 per equity share
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021
Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021
The jump in profit is due to the better performance of the API business.
The company has posted net profit of Rs.397.06 crores for the 9 months period ended December 31, 2020.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
